Current Anti-Amyloid-β Therapy for Alzheimer’s Disease Treatment: From Clinical Research to Nanomedicine
Open Access
- 1 December 2023
- journal article
- review article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 18, 7825-7845
Abstract
Recent successive approval of anti-amyloid-β (Aβ) monoclonal antibodies as disease-modifying therapies against Alzheimer’s disease (AD) has raised great confidence in the development of anti-AD therapies; however, the current therapies still face the dilemma of significant adverse reactions and limited effects. In this review, we summarized the therapeutic characteristics of the approved anti-Aβ immunotherapies and dialectically analyzed the gains and losses from clinical trials. The review further proposed the reasonable selection of animal models in preclinical studies from the perspective of different animal models of Aβ deposition and deals in-depth with the recent advances of exploring preclinical nanomedical application in Aβ targeted therapy, aiming to provide a reliable systematic summary for the development of novel anti-Aβ therapies. Collectively, this review comprehensively dissects the pioneering work of Aβ-targeted therapies and proposed perspective insight into AD-modified therapies.Keywords
This publication has 123 references indexed in Scilit:
- Pyroglutamate Amyloid-β (Aβ): A Hatchet Man in Alzheimer DiseaseJournal of Biological Chemistry, 2011
- Decreased Clearance of CNS β-Amyloid in Alzheimer’s DiseaseScience, 2010
- Murine models of Alzheimer's disease and their use in developing immunotherapiesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domainProceedings of the National Academy of Sciences, 2009
- Discovery of potent β-secretase (bace-1) inhibitors by the synthesis of isophthalamide-containing hybridsActa Pharmacologica Sinica, 2009
- Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease MiceThe Journal of Neuroscience, 2008
- Construction of a small peptide library related to inhibitor OM99-2 and its structure-activity relationship to ?-secretaseActa Pharmacologica Sinica, 2006
- Early-onset and Robust Cerebral Microvascular Accumulation of Amyloid β-Protein in Transgenic Mice Expressing Low Levels of a Vasculotropic Dutch/Iowa Mutant Form of Amyloid β-Protein PrecursorJournal of Biological Chemistry, 2004
- Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoformsJournal of Neurochemistry, 2003
- Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease modelAnnals of Neurology, 2000